Bringing the Oncology Community Together

In March, a one-day conference will provide specialists with practical information they need to provide their patients with the best in diagnostic and therapeutic care.

Oncology Live   >   Specialty Focus

Bevacizumab improved progression-free survival in patients with ovarian cancer but was not shown to affect overall survival.

Oncology Live   >   Specialty Focus

The FDA announced plans to strengthen the supply of 2 scarce cancer drugs: methotrexate and Doxil.

  >   Web Exclusives

The 9th International Symposium on Ovarian Cancer and Other Gynecologic Malignancies conference will bring professionals in the field up to date on the latest research into ovarian, uterine, cervical, and endometrial cancers.

Oncology Live   >   Specialty Focus

This commentary will highlight 2 phase III randomized trials and a retrospective review of a large national database that has been strongly criticized based on its overall conclusions.

Oncology Live   >   Conference Highlights

New data show that roughly one-fifth of tamoxifen-treated male patients with breast cancer stop treatment early because of side effects.

Oncology & Biotech News   >   Clinical Trial Reports

Researchers are dissecting new studies regarding targeted therapies as well as combined therapeutic approaches for HPV in the progression of head and neck cancers.

Oncology Live   >   Specialty Focus

Outpatient management in patients with cancer who have a low risk of severe febrile neutropenia is an effective and safe option to standard inpatient treatment.

Oncology & Biotech News   >   Clinical Trial Reports

The use of a navigation program for an urban safety net breast cancer population has only a moderate effect on the time from symptom presentation to treatment.

Oncology & Biotech News   >   Clinical Trial Reports

Supportive care is a crucial component of personalized oncology care.

Oncology Live   >   Specialty Focus